ERN1 and cancer: XBP1s overexpression in cancer cells can directly promote tumorigenesis, such as in chronic lymphocytic leukemia20, and targeting activated IRE1α and subsequent XBP1 splicing had promising results in preclinical models in multiple myeloma6.